Finance
Finance
MwanzoHELP • NASDAQ
Cybin Inc
$ 7.90
3 Mac, 16:15:05 GMT -5 · USD · NASDAQ · Kanusho
HisaHisa zinazouzwa MarekaniMakao yake makuu ni CA
Bei iliyotangulia
$ 7.61
Bei za siku
$ 7.22 - $ 8.10
Bei za mwaka
$ 5.76 - $ 8.97
Wastani wa hisa zilizouzwa
elfu 520.82
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CAD)Mac 2025Mabadiliko Tangu Mwaka Uliopita
Mapato
Matumizi ya uendeshaji wa biashara
33.24M31.95%
Mapato halisi
-30.58M-43.25%
Kiwango cha faida halisi
Mapato kwa kila hisa
-1.46-92.11%
EBITDA
-33.19M-32.03%
Asilimia ya kodi ya mapato
Jumla ya mali
Jumla ya dhima
(CAD)Mac 2025Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
135.02M-35.39%
Jumla ya mali
258.62M-14.37%
Jumla ya dhima
21.42M112.14%
Jumla ya hisa
237.20M
hisa zilizosalia
23.03M
Uwiano wa bei na thamani
0.69
Faida inayotokana na mali
-32.45%
Faida inayotokana mtaji
-34.81%
Mabadiliko halisi ya pesa taslimu
(CAD)Mac 2025Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-30.58M-43.25%
Pesa kutokana na shughuli
-21.11M-1.96%
Pesa kutokana na uwekezaji
-1.08M-404.19%
Pesa kutokana na ufadhili
20.98M-89.01%
Mabadiliko halisi ya pesa taslimu
-1.27M-100.75%
Mtiririko huru wa pesa
-11.14M12.30%
Kuhusu
Helus Pharma, also known formerly as Cybin IRL, is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines. The company's drug candidates include psilocybin, HLP002, HLP003, HLP004, HLP005, and HLP006. Another drug that the company has developed is CYB210010. As of January 2025, HLP003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development. In 2020, Helus Pharma acquired psychedelic pharmaceutical company Adelia Therapeutics. Helus Pharma was originally known as Cybin but changed its name in December 2025. Wikipedia
Ilianzishwa
2019
Tovuti
Wafanyakazi
50
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu